Official Journal of the Chinese Society for Microbiology
Virologica Sinica is an international journal which aims at presenting the cutting-edge basic and applied research on viruses all over the world. The journal publishes peer-reviewed original research articles and reviews, as well as commentaries and letters to the editor, to encompass the latest developments in all branches of virology, including research on animal, plant and microbe viruses. The journal welcomes articles on virus discovery, viral pathogenesis, virus-host interaction, vaccine development, antiviral agents and therapies, and virus related bio-techniques. Virologica Sinica, the official journal of Chinese Society for Microbiology, will serve as a platform for the communication and exchange of academic information and ideas in an international context.
The journal editorial board is composed of virologists, immunologists, biologists from a broad range of research fields worldwide to maintain the high standard of excellence for the journal. All submissions to Virologica Sinica are handled electronically, via ScholarOne online submission and review system. The journal is indexed by many international databases: Science Citation Index Expanded (also known as SciSearch®), Journal Citation Reports/ Science Edition, PubMed/Medline, Scopus, BIOSIS Previews®, EMBASE, Google Scholar, SCImago, and etc.
The journal follows a single-blind peer review. For details, each member of the Editorial Board can act as the Executive Editor of a submission and coordinate the peer review process. Upon receipt of a submission, the editorial office performs an initial check, after which the paper is assigned to an Executive Editor, whose area of expertise matches with the manuscript subject area. The Executive Editor coordinates the peer review process, and invites two or more referees to perform critical reviews and provide confidential comments, whereby a two-week period is the guideline to review a manuscript. Based on the referees’ review, the Executive Editor makes a decision for the manuscript (accept, minor revision, major revision, reject). The Editor-in-Chief renders the final publication decisions.
Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression
To view the rest of this content please follow the download PDF link above.